Business & regional news

Month Year

Month Year

Your search returned 113 results

Nov 4, 2024

New data adds to body of research demonstrating safety and effectiveness of atherectomy

Comparative data and systematic literature review released at VIVA 2024 show breadth and depth of data supporting atherectomy as a treatment for peripheral arterial disease
- Peripheral Vascular Health
Oct 28, 2024

Medtronic appoints Dr. Matthew Kroh as Chief Medical Officer for Advanced and General Surgical Technologies
- Surgical
Oct 23, 2024

Medtronic received FDA approval for IDE Trial for its Prevail™ drug coated balloon
- Coronary and Renal Denervation
Oct 11, 2024

Medtronic announces FDA approval for early feasibility trial of Affera™ Mapping and Ablation System with Sphere-9™ Catheter for the treatment of ventricular tachycardia

The VT research will provide important clinical evidence in an underserved patient population
- Cardiac Ablation Solutions
Oct 8, 2024

Medtronic launches the Avalus Ultra™ valve in Western Europe at the European Association for Cardio-Thoracic Surgery (EACTS) Congress

Global expansion of the Avalus Ultra valve continues in Western Europe while company highlights robust, innovative Cardiac Surgery portfolio at EACTS in Lisbon
- Cardiac Surgery
Sep 25, 2024

Medtronic Symplicity™ blood pressure procedure named to FORTUNE 2024 ‘Change the World’ list

Company recognized among top 52 global companies making positive social impact through core business strategy
- Coronary and Renal Denervation
Sep 24, 2024

Medtronic to showcase real-world application of exclusive BrainSense™ technology and groundbreaking DBS research at the 2024 International Congress of Parkinson’s Disease and Movement Disorders®
- Neuromodulation
Sep 17, 2024

Medtronic pioneering ADAPT-PD clinical trial methods manuscript published, setting new standards in Parkinson's disease research

ADAPT-PD trial methods and preliminary data published in npj Parkinson’s disease
- Neuromodulation
Sep 4, 2024

Medtronic to present new data regarding use of the MiniMed™ 780G system among broader population at the European Association for the Study of Diabetes (EASD) 60th Annual Meeting

The company will present clinical evidence in young children, pregnancy and type 2 diabetes*
- Diabetes
Aug 22, 2024

First enrollment completed in REAL-Pulse, PulseSelect™ pulsed field ablation system global registry, as demand and adoption continue to increase

Post-market data collection will add real-world experience to established safety, efficacy, and efficiency evidence profile
- Cardiac Ablation Solutions

Show per page